Related Experiment Videos

[Budd-Chiari syndrome illustrated by four case reports]

Henning Grønbaek1, Dennis Tønner Nielsen, Lone Bording Astrup

  • 1Medicinsk afdeling V og radiologisk afdeling R, Arhus Kommunehospital, Arhus Universitetshospital, DK-8000 Arhus C. henning.gronbaek@dadlnet.dk

Ugeskrift for Laeger
|July 11, 2002
PubMed

Insights

Budd-Chiari syndrome (BCS) management requires individualized treatment plans. Diverse patient cases highlight successful interventions including TIPS, venesection, anticoagulation, liver transplantation, and stenting for hepatic venous obstruction.

Area of Science:

  • Hepatology
  • Vascular Medicine
  • Interventional Radiology

Background:

  • Budd-Chiari syndrome (BCS) is characterized by hepatic venous outflow obstruction.
  • Patient management is complex due to variations in obstruction location, etiology, and disease progression.

Observation:

  • Four distinct BCS cases were presented.
  • Case 1: Protein C deficiency, oral contraceptive use, smoking; treated with transjugular intrahepatic portosystemic shunt (TIPS).
  • Case 2: Polycythemia vera; treated with venesection and anticoagulation.
  • Case 3: Underwent liver transplantation.
  • Case 4: Congenital vascular web; treated with stenting.

Findings:

  • Successful outcomes were achieved with tailored interventions for each patient.
  • Transjugular intrahepatic portosystemic shunt (TIPS) proved effective for a patient with multiple risk factors.
  • Medical management (venesection, anticoagulation) and surgical options (liver transplant, stenting) were successful in other cases.

Implications:

  • Individualized treatment strategies are crucial for managing Budd-Chiari syndrome.
  • A range of interventional and surgical options can effectively address hepatic venous obstruction.
  • Understanding patient-specific factors is key to selecting the optimal therapeutic approach for BCS.

Related Concept Videos